CurifyLabs

CurifyLabs

Private
HelsinkiHealthcare & Life Scienceshttps://curifylabs.com/

Last Round

Debt

May 27, 2025

Total Funding Raised

$13.89M

Momentum Score

50 /100

Company Overview

CurifyLabs is a healthtech company that provides an automated platform for compounding personalized medicines for pharmacies and hospitals.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical Devices, 3D Printing, Workflow Automation, Pharma Supply Chain

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

automated compoundingpharmaceutical 3D printingcompounding automationpersonalized medicine3D printed medicinecompounding roboticshospital pharmacy automationrobotic compoundingnon-sterile compoundingformulation libraryGMP excipientsdigital batch recordshealthtechveterinary compoundingUSP <795> compliance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CurifyLabs Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CurifyLabs Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtMay 27, 2025
Series AMay 27, 2025
DebtMar 4, 2024
GrantApr 3, 2023
SeedNov 1, 2022

Key People

Founding team and executive leadership

Charlotta Topelius

Chief Executive Officer

Executive Team

Timo Ala-Kokkila

CFO

Executive Team

CurifyLabs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 18, 2026

    Grew 21% QoQ from 29 to 35 employees.

  • Jan 21, 2026

    Monthly visitors increased 178% MoM, reaching 4.1K.

CurifyLabs Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CurifyLabs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CurifyLabs's valuation, stock price, and market status.

Firmographic Details

HeadquartersHelsinki
Employee Range35
Year Founded2021
Last FundingMay 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.